Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

NCT00189670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Node Positive Breast Cancer

Interventions

PROCEDURE: 6 TEC q 3 weeks
PROCEDURE: 4 EC q 2 weeks followed by 4 TXT q 2 weeks
PROCEDURE: 4 TXT q 2 weeks followed by 4 EC q 2 weeks

Sponsor

Association Européenne de Recherche en Oncologie

Collaborators

[object Object]
[object Object]